Gossamer Bio Inc (GOSS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $67.10M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 4.6% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 54.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about GOSS
GNG News
All GOSS news- GOSSChardan Capital initiates coverage of Gossamer Bio (GOSS) at Buy
UpdatedHistorical
News
GOSS Valuation
GOSS Profitability: Margins, ROIC and FCF
Gossamer Bio (GOSS) has a gross margin of 100.0%, an operating margin of -136.5% and a net margin of -159.5%. It posts 147.4% ROIC and a -199.0% FCF margin.
- Gross margin
- 100.0%
- Operating margin
- -136.5%
- Net margin
- -159.5%
- ROIC
- 147.4%
- ROE
- -783.0%
- FCF margin
- -199.0%
Gossamer Bio Competitors
The companies most similar to Gossamer Bio (GOSS) include ImageneBio, Coherus BioSciences and Genelux Corporation Common Stock.
Sector: Healthcare
Companies most similar to Gossamer BioGOSS Analyst Ratings
Gossamer Bio (GOSS) has a Hold consensus from 8 analysts: 4 Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell.
- Consensus
- Hold
- Analysts
- 8
- Strong Buy
- 1
- Buy
- 3
- Hold
- 3
- Sell
- 0
- Strong Sell
- 1
GOSS Bull Case vs Bear Case
Bull case
- GOSS earns a 147.4% return on invested capital.
- GOSS grew quarterly revenue 189.1% year over year.
Bear case
- GOSS has a -159.5% net profit margin.
GOSS Earnings: Beat Rate and Next Report
Gossamer Bio (GOSS) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 15, 2027.
- Beat rate
- 4 of 8 quarters (50.0%)
- Average surprise
- -4.5%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$3.23
GOSS Earnings Date
GOSS reports Mar 15, 2027. The date is estimated.
GOSS Earnings Call
The latest GOSS earnings call transcript on file is labeled 2026Q1.
Read the 2026Q1 transcriptGOSS ETF Holders
GNG tracks 8 ETFs that hold GOSS. The largest weights:
- iShares Russell 2000 ETF (IWM), 0.02% of the fund
- Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.02% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), 0.01% of the fund
- BlackRock Health Sciences Trust (BME), <0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About GOSS
When does GOSS report earnings?
Gossamer Bio Inc (GOSS) is expected to report earnings on Mar 15, 2027.
Does GOSS pay dividends?
Gossamer Bio Inc (GOSS) does not currently pay a regular dividend.
What is GOSS's market cap?
Gossamer Bio Inc (GOSS) has a market capitalization of $67.10M with a current stock price of $10.98.
GOSS pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.